Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 174526, 8 pages
http://dx.doi.org/10.1155/2013/174526
Research Article

Benidipine Protects Kidney through Inhibiting ROCK1 Activity and Reducing the Epithelium-Mesenchymal Transdifferentiation in Type 1 Diabetic Rats

1Hubei Province Key Laboratory on Cardiovascular, Cerebrovascular, and Metabolic Disorders, Hubei University of Science and Technology, Xianning 437100, China
2Department of Medicine, Clinic Medical College of Hubei University of Science and Technology, Xianning 437100, China
3Department of Medicine, The Second Affiliated Hospital of Hubei University of Science and Technology, Xianning 437100, China
4Department of Immunology, Wuhan University of Science and Technology, Wuhan 430081, China

Received 13 May 2013; Revised 18 July 2013; Accepted 19 August 2013

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2013 Ganlin Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Furukawa, T. Nukada, R. Miura et al., “Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (α1G) expressed in Xenopus oocytes,” Journal of Cardiovascular Pharmacology, vol. 45, no. 3, pp. 241–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Prakash, M. H. De Borst, M. Lacombe et al., “Inhibition of renal Rho kinase attenuates ischemia/reperfusion-induced injury,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2086–2097, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Masszi, C. Di Ciano, G. Sirokmány et al., “Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition,” American Journal of Physiology: Renal Physiology, vol. 284, no. 5, pp. F911–F924, 2003. View at Google Scholar · View at Scopus
  4. K. Nagatoya, T. Moriyama, N. Kawada et al., “γ-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction,” Kidney International, vol. 61, no. 5, pp. 1684–1695, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Sugano, S. Wakino, T. Kanda et al., “T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy,” Kidney International, vol. 73, no. 7, pp. 826–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Meyer-Schwesinger, S. Dehde, M. Sachs et al., “Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis,” American Journal of Physiology: Renal Physiology, vol. 303, no. 7, pp. F1015–F1025, 2012. View at Google Scholar
  7. C. Hahmann and T. Schroeter, “Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity,” Cellular and Molecular Life Sciences, vol. 67, no. 2, pp. 171–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S.-Y. Gao, C.-Y. Li, J. Chen et al., “Rho-ROCK signal pathway regulates microtubule-based process formation of cultured podocytes—inhibition of ROCK promoted process elongation,” Nephron, vol. 97, no. 2, pp. e49–e61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Gu, Q. Gao, L. Ni, M. Wang, and S. F. Fasudil, “Inhibits epithelial-myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose,” Chemical and Pharmaceutical Bulletin, vol. 61, no. 7, pp. 688–694, 2013. View at Google Scholar
  10. V. Mauri, P. Lotfi, L. Segatori, and M. Sardiello, “A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells,” PLoS ONE, vol. 8, no. 6, Article ID e68060, 2013. View at Google Scholar
  11. S. Jeruschke, A. K. Büscher, J. Oh et al., “Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling,” PLoS ONE, vol. 8, no. 2, Article ID e55980, 2013. View at Google Scholar
  12. N. Wettschureck and S. Offermanns, “Rho/Rho-kinase mediated signaling in physiology and pathophysiology,” Journal of Molecular Medicine, vol. 80, pp. 629–638, 2002. View at Publisher · View at Google Scholar
  13. L. A. Bach, “Rho kinase inhibition: a new approach for treating diabetic nephropathy?” Diabetes, vol. 57, no. 3, pp. 532–533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Kolavennu, L. Zeng, H. Peng, Y. Wang, and F. R. Danesh, “Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control,” Diabetes, vol. 57, no. 3, pp. 714–723, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Yao, K. Nagashima, and H. Miki, “Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker,” Journal of Pharmacological Sciences, vol. 100, no. 4, pp. 243–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Matsubara and K. Hasegawa, “Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells,” European Journal of Pharmacology, vol. 498, no. 1–3, pp. 303–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Akizuki, A. Inayoshi, T. Kitayama et al., “Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R,” European Journal of Pharmacology, vol. 584, no. 2-3, pp. 424–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Jesmin, Y. Hattori, S. Maeda, S. Zaedi, I. Sakuma, and T. Miyauchi, “Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 290, no. 5, pp. H2146–H2154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Ono, N. Liu, H. Kusano et al., “Broad antiproliferative effects of benidipine on cultured human mesangial cells in cell cycle phases,” American Journal of Nephrology, vol. 22, no. 5-6, pp. 581–586, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Freise, M. Ruehl, D. Seehofer, J. Hoyer, and R. Somasundaram, “The inhibitor of Ca2+-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB,” Investigational New Drugs, 2012. View at Google Scholar
  21. F. Pluteanu and L. L. Cribbs, “Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells,” American Journal of Physiology: Cell Physiology, vol. 300, no. 3, pp. C517–C525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Yamamoto, N. Shioda, F. Han, S. Moriguchi, and K. Fukunaga, “The novel cognitive enhancer ST101 enhances acetylcholine release in mouse sorsal hippocampus through T-type voltage-gated calcium channel stimulation,” Journal of Pharmacological Sciences, 2013. View at Google Scholar
  23. L. Howitt, I. Y. Kuo, A. Ellis et al., “Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium channel contribution to vascular tone of rodent arteries and arterioles,” Cardiovascular Research, 2013. View at Google Scholar